Literature DB >> 17339398

Chemokines and chemokine receptors in the brain: implication in neuroendocrine regulation.

Céline Callewaere1, Ghazal Banisadr, William Rostène, Stéphane Mélik Parsadaniantz.   

Abstract

Chemokines are small secreted proteins that chemoattract and activate immune and non-immune cells both in vivo and in vitro. In addition to their well-established role in the immune system, several recent reports have suggested that chemokines and their receptors may also play a role in the central nervous system (CNS). The best known central action is their ability to act as immunoinflammatory mediators. Indeed, these proteins regulate leukocyte infiltration in the brain during inflammatory and infectious diseases. However, we and others recently demonstrated that they are expressed not only in neuroinflammatory conditions, but also constitutively by different cell types including neurons in the normal brain, suggesting that they may act as modulators of neuronal functions. The goal of this review is to highlight the role of chemokines in the control of neuroendocrine functions. First, we will focus on the expression of chemokines and their receptors in the CNS, with the main spotlight on the neuronal expression in the hypothalamo-pituitary system. Secondly, we will discuss the role--we can now suspect--of chemokines and their receptors in the regulation of neuroendocrine functions. In conclusion, we propose that chemokines can be added to the well-described neuroendocrine regulatory mechanisms, providing an additional fine modulatory tuning system in physiological conditions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17339398     DOI: 10.1677/JME-06-0035

Source DB:  PubMed          Journal:  J Mol Endocrinol        ISSN: 0952-5041            Impact factor:   5.098


  38 in total

1.  Involvement of calcitonin gene-related peptide and CCL2 production in CD40-mediated behavioral hypersensitivity in a model of neuropathic pain.

Authors:  Jennifer T Malon; Swathi Maddula; Harmony Bell; Ling Cao
Journal:  Neuron Glia Biol       Date:  2012-03-01

2.  Anti-nociceptive Role of CXCL1 in a Murine Model of Peripheral Nerve Injury-induced Neuropathic Pain.

Authors:  Ling Cao; Jennifer T Malon
Journal:  Neuroscience       Date:  2018-01-06       Impact factor: 3.590

3.  NPY receptors as potential targets for anti-obesity drug development.

Authors:  Ernie Yulyaningsih; Lei Zhang; Herbert Herzog; Amanda Sainsbury
Journal:  Br J Pharmacol       Date:  2011-07       Impact factor: 8.739

4.  Mexneurin is a novel precursor of peptides in the central nervous system of rodents.

Authors:  Maura E Matus-Ortega; Philippe Leff Gelman; Juan C Calva-Nieves; Anabel Flores-Zamora; Alberto Salazar-Juárez; Carlos-Alejandro Torner-Aguilar; Gerardo Gamba; Paola De Los Heros; Bonnie Peng; John E Pintar; Heinrich S Gompf; Charles N Allen; Benito Antón-Palma
Journal:  FEBS Lett       Date:  2017-06-01       Impact factor: 4.124

5.  Central CCL2 signaling onto MCH neurons mediates metabolic and behavioral adaptation to inflammation.

Authors:  Ophélia Le Thuc; Céline Cansell; Miled Bourourou; Raphaël Gp Denis; Katharina Stobbe; Nadège Devaux; Alice Guyon; Julie Cazareth; Catherine Heurteaux; William Rostène; Serge Luquet; Nicolas Blondeau; Jean-Louis Nahon; Carole Rovère
Journal:  EMBO Rep       Date:  2016-10-12       Impact factor: 8.807

6.  Differential effects of systemic interleukin-1β on gene expression in brainstem noradrenergic nuclei.

Authors:  Madhu P Sirivelu; P S MohanKumar; Sheba M J MohanKumar
Journal:  Life Sci       Date:  2011-10-20       Impact factor: 5.037

7.  Production of proinflammatory cytokines and chemokines during neuroinflammation: novel roles for estrogen receptors alpha and beta.

Authors:  Candice M Brown; Tara A Mulcahey; Nicole C Filipek; Phyllis M Wise
Journal:  Endocrinology       Date:  2010-08-04       Impact factor: 4.736

Review 8.  Monocyte chemoattractant protein-1 (MCP-1): an overview.

Authors:  Satish L Deshmane; Sergey Kremlev; Shohreh Amini; Bassel E Sawaya
Journal:  J Interferon Cytokine Res       Date:  2009-06       Impact factor: 2.607

9.  Intracerebroventricular injection of leukotriene B4 attenuates antigen-induced asthmatic response via BLT1 receptor stimulating HPA-axis in sensitized rats.

Authors:  Shui-Juan Zhang; Yang-Mei Deng; Yi-Liang Zhu; Xin-Wei Dong; Jun-Xia Jiang; Qiang-Min Xie
Journal:  Respir Res       Date:  2010-04-20

10.  Leukotriene B4, administered via intracerebroventricular injection, attenuates the antigen-induced asthmatic response in sensitized guinea pigs.

Authors:  Yi-Liang Zhu; Shui-Jun Zhang; Yang-Mei Deng; Xin-Wei Dong; Jun-Xia Jiang; Qiang-Min Xie
Journal:  J Neuroinflammation       Date:  2010-02-11       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.